Sleep Disturbances in Menopause

Newly published data from a phase 3 study demonstrate the safety and efficacy of fezolinetant (Astellas) for treatment of VMS due to menopause.

In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.

The new guidance is the first update since 2008, replacing the previous risk-based recommendations.

In this episode, Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist, and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.

Michael Krychman, MD, digital editor for Contemporary OB/GYN® recently attended the International Society for the Study of Women’s Sexual Health (ISSWSH), held March 2 through March 5 in St. Louis, Missouri. There he spoke to Andrew Goldstein, MD, a board-certified ob gyn who practices in Annapolis, Maryland and is the past president of ISSWSH.

Individuals that did not respond had a lower percentage of naïve T cells compared to responders, while responders had a lower percentage of Th2 and CD4 central memory subsets before vaccination.